This study identifies AQP3 and CD24 as biomarkers for carcinogenesis of GIM, and improves our understanding of the mechanism of carcinogenesis from GIM to GC and may provide a precise strategy for screening at-risk candidates with GIM. This evidence concerns the gene CD24 and gastric cancer.